Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 10,036 shares at $55.04 ($553K) on 2007-10-15, disclosed to the SEC on 2007-10-16.
Scheduled sale ($553k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 4,527 | $249K | 45.0% |
| 2 | $55.03 | 1,000 | $55K | 9.9% |
| 3 | $55.04 | 600 | $33K | 6.0% |
| 4 | $55.05 | 200 | $11K | 2.0% |
| 5 | $55.06 | 200 | $11K | 2.0% |
| 6 | $55.07 | 200 |
| $11K |
| 2.0% |
| 7 | $55.23 | 200 | $11K | 2.0% |
| 8 | $55.25 | 1,865 | $103K | 18.6% |
| 9 | $55.26 | 573 | $32K | 5.7% |
| 10 | $55.29 | 100 | $6K | 1.0% |
| 11 | $55.32 | 55 | $3K | 0.6% |
| 12 | $55.66 | 344 | $19K | 3.5% |
| 13 | $55.70 | 172 | $10K | 1.7% |
| Total | $55.11 avg | 10,036 | $553K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |